Biofrontera Reports Q3 Revenue Beat Amid Earnings Miss
Biofrontera (BFRI) reported third-quarter financial results characterized by a significant divergence between top-line growth and bottom-line performance. The company achieved revenue of $9.07 million, representing a 29.9% increase year-over-year and exceeding analyst expectations by $0.82 million. Despite the revenue beat, Biofrontera reported a GAAP earnings per share (EPS) of -$0.42, missing consensus estimates by $0.20. This indicates that while sales momentum is accelerating, operational costs or other non-operating expenses continue to weigh heavily on profitability.
Tickers: $BFAGY.CNV
Topics: earnings miss GAAP EPS revenue beat
Read the full article at Seeking Alpha
Part of the story Corteva Shares Plunge Over Q3 Earnings Miss and Pricing Pressures (6 articles)